Heterobimetallic Chromium Manganese Carbonyl Nitrosyls: Comparison with Isoelectronic Homometallic Binuclear Chromium Carbonyl Nitrosyls and Manganese Carbonyls

The heterometallic chromium-manganese carbonyl nitrosyls CrMn(NO)(CO)n (n = 9, 8) have been investigated by density functional theory. The lowest energy CrMn(NO)(CO)9 structures have unbridged staggered conformations with a ~2.99 Å Cr–Mn single bond similar to the experimental and lowest energy structures of the isoelectronic Mn2(CO)10 and Cr2(NO)2(CO)8. A significantly higher energy CrMn(NO)(CO)9 isomer has a nearly symmetrical bridging nitrosyl group and a very weakly semibridging carbonyl group. The two lowest energy structures of the unsaturated CrMn(NO)(CO)8 have a five-electron donor bridging η2-µ-NO nitrosyl group or a four-electron donor bridging η2-µ-CO group, as well as a Cr–Mn single bond of length ~2.94 Å. The next higher energy CrMn(NO)(CO)8 structure has exclusively terminal CO and NO ligands and a shorter Cr–Mn single bond of ~2.85 Å, suggesting an 18-electron configuration for the manganese atom and a 16-electron configuration for the chromium atom indicated by a vacant coordination site nearly perpendicular to the Cr–Mn bond.

Crystal structures of four dimeric manganese(II) bromide coordination complexes with various derivatives of pyridine N-oxide

Four manganese(II) bromide coordination complexes have been prepared with four pyridine N-oxides, viz. pyridine N-oxide (PNO), 2-methylpyridine N-oxide (2MePNO), 3-methylpyridine N-oxide (3MePNO), and 4-methylpyridine N-oxide (4MePNO). The compounds are bis(μ-pyridine N-oxide)bis[aquadibromido(pyridine N-oxide)manganese(II)], [Mn2Br4(C5H5NO)4(H2O)2] (I), bis(μ-2-methylpyridine N-oxide)bis[diaquadibromidomanganese(II)]–2-methylpyridine N-oxide (1/2), [Mn2Br4(C6H7NO)2(H2O)4]·2C6H7NO (II), bis(μ-3-methylpyridine N-oxide)bis[aquadibromido(3-methylpyridine N-oxide)manganese(II)], [Mn2Br4(C6H7NO)4(H2O)2] (III), and bis(μ-4-methylpyridine N-oxide)bis[dibromidomethanol(4-methylpyridine N-oxide)manganese(II)], [Mn2Br4(C6H7NO)4(CH3OH)2] (IV). All the compounds have one unique MnII atom and form a dimeric complex that contains two MnII atoms related by a crystallographic inversion center. Pseudo-octahedral six-coordinate manganese(II) centers are found in all four compounds. All four compounds form dimers of Mn atoms bridged by the oxygen atom of the PNO ligand. Compounds I, II and III exhibit a bound water of solvation, whereas compound IV contains a bound methanol molecule of solvation. Compounds I, III and IV exhibit the same arrangement of molecules around each manganese atom, ligated by two bromide ions, oxygen atoms of two PNO ligands and one solvent molecule, whereas in compound II each manganese atom is ligated by two bromide ions, one O atom of a PNO ligand and two water molecules with a second PNO molecule interacting with the complex via hydrogen bonding through the bound water molecules. All of the compounds form extended hydrogen-bonding networks, and compounds I, II, and IV exhibit offset π-stacking between PNO ligands of neighboring dimers.

Synthesis, characterization and antibacterial susceptibility testing of manganese complexes of doxycyline with bipyridine and phenanthroline

Three manganese complexes of the antibiotic doxycyline viz.: manganese doxycyline, [MnDox2]Cl2‧2H2O (1), and manganese doxycyline with bipyridine, [MnDox2(bpy)]Cl2‧8H2O (2), and phenanthroline, [MnDox2(phen)]Cl2‧8H2O (3), as the ancillary ligand were synthesized and characterized by FT-IR, elemental analysis and electrospray mass spectroscopy. The three complexes show good solubility in DMF and DMSO. Data obtained from spectroscopic techniques used show that doxycycline coordinates to the central manganese atom through the oxygen of the amide group and the carbonyl oxygen atom of ring A while bipyridine/phenanthroline coordinates through the two diimine nitrogen atoms. The stoichiometry of manganese-doxycycline is 1:2 and octahedral geometry is the preferred coordination in all the complexes.